Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 40 | 74 | 33 | 21 | 433 |
| Gross Profit | 40 | 74 | 33 | 21 | 433 |
| Operating Expenses | 7,094 | 7,231 | 6,910 | 5,236 | 9,122 |
| Operating Income | -7,054 | -7,157 | -6,877 | -5,215 | -8,689 |
| Interest Expense | 0 | 0 | 0 | 48 | 0 |
| Other Income | -13 | 6,490 | 98 | 140 | 430 |
| Pre-tax Income | -7,067 | -667 | -6,779 | -5,123 | -8,259 |
| Income Tax | -4,652 | -2,432 | -1,426 | -5,463 | -12 |
| Net Income Continuous | -2,415 | 1,765 | -5,353 | 340 | -8,247 |
| Net Income | $-2,415 | $1,765 | $-5,353 | $340 | $-8,247 |
| EPS Basic Total Ops | -0.35 | 0.21 | -0.65 | -0.14 | -1.98 |
| EPS Basic Continuous Ops | -0.56 | 0.21 | -0.65 | 0.16 | -1.99 |
| EPS Diluted Total Ops | -0.35 | 0.21 | -0.65 | -0.14 | -1.98 |
| EPS Diluted Continuous Ops | -0.55 | 0.21 | -0.65 | 0.16 | -1.99 |
| EBITDA(a) | $-6,845 | $-7,002 | $-6,666 | $-5,206 | $-8,675 |